ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "C09BA05" (15)Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
Ramipril and Diuretics (C09BA05) 15 products WHO-DDD DrugBank.ca 
  IPCI Triatec comp mite20 Tablet(s)4.2713.8510 %Tablets: 2 Active AgentsSanofi-Aventis
(Suisse) SA
B / SL / SOG
  IPCI Triatec comp mite100 Tablet(s)18.1135.9510 %Tablets: 2 Active AgentsSanofi-Aventis
(Suisse) SA
B / SL / SOG
  IPCI Triatec comp20 Tablet(s)4.6414.2510 %Tablets: 2 Active AgentsSanofi-Aventis
(Suisse) SA
B / SL / SOG
  IPCI Triatec comp100 Tablet(s)20.1638.1510 %Tablets: 2 Active AgentsSanofi-Aventis
(Suisse) SA
B / SL / SOG
  IPCI Co-Ramipril Sandoz
2.5/12.5
20 Tablet(s)3.6313.2010 %Tablets: 2 Active AgentsSandoz
Pharmaceuticals AG
B / SL / SGG
  IPCI Co-Ramipril Sandoz
2.5/12.5
100 Tablet(s)15.3833.1510 %Tablets: 2 Active AgentsSandoz
Pharmaceuticals AG
● B / SL / SGG
  IPCI Co-Ramipril Sandoz 5/2520 Tablet(s)3.9413.5010 %Tablets: 2 Active AgentsSandoz
Pharmaceuticals AG
B / SL / SGG
  IPCI Co-Ramipril Sandoz 5/25100 Tablet(s)17.1435.0510 %Tablets: 2 Active AgentsSandoz
Pharmaceuticals AG
B / SL / SGG
  IPCI Ramipril HCT Zentiva
2.5/12.5 mg
20 Tablet(s)3.6413.2010 %Tablets: 2 Active AgentsHelvepharm AGB / SL / SGG
  IPCI Ramipril HCT Zentiva
2.5/12.5 mg
100 Tablet(s)15.4033.1510 %Tablets: 2 Active AgentsHelvepharm AGB / SL / SGG
  IPCI Ramipril HCT Zentiva 5/25 mg20 Tablet(s)3.9413.5010 %Tablets: 2 Active AgentsHelvepharm AGB / SL / SGG
  IPCI Ramipril HCT Zentiva 5/25 mg100 Tablet(s)17.1435.0510 %Tablets: 2 Active AgentsHelvepharm AGB / SL / SGG
  IP  Pepcid AC6 Kautablettenk.A.Chewing tablets: Famotidinum 10 mgMSD Merck Sharp &
Dohme AG
CG
  IP  Pepcid AC12 Kautablettenk.A.Chewing tablets: Famotidinum 10 mgMSD Merck Sharp &
Dohme AG
CG
  IPCI Ramipril-HCT-Mepha 5/25 mg10018.3437.45k.A.Tablets: 2 Active AgentsMepha Pharma AGBG
 show caption
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home